Viromed Medical AG (VME)
XETR
5.75
+0.05 (+0.88%)
Closed
Oct 6, 2026
Day's Range
5.605.85
52 wk Range
2.608.45
Financial Statements - VME - Viromed Medical AG
Revenue
5.08M▲ 352.3%
Net Income
604.51K▲ 119.5%Net Margin 11.9%
EBITDA
-9.50K▲ 99.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 5.08M | 1.12M | 0 | 0 |
| Cost of Goods | 2.80M | 1.41M | - | - |
| Gross Profit | 2.28M | -287.91K | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -862.27K | -3.49M | -358.95K | -160.47K |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | -729.86K | -4.11M | -110.41K | -160.61K |
| Income Tax | -1.33M | -1.02M | - | - |
| Net Income | 604.51K | -3.09M | -110.41K | -160.61K |
| EPS Basic | 0.028448 | -0.152721 | -0.005452 | - |
| EPS Diluted | 0.028448 | -0.152721 | -0.005452 | - |
| Basic Shares Outstanding | 21.25M | 20.25M | 20.25M | - |
| Diluted Shares Outstanding | 21.25M | 20.25M | 20.25M | - |
| Ebit | -534.13K | -3.39M | -108.95K | -160.47K |
| Ebitda | -9.50K | -3.13M | -108.95K | -160.47K |
| Net Income Continuous Operations | - | - | - | - |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
